LightPath Technologies (LPTH) Is Up 12.6% After Revenue Doubles But Losses Widen – Has The Bull Case Changed?

  • LightPath Technologies reported past third-quarter 2026 results showing sales of US$19.15 million versus US$9.17 million a year earlier, while quarterly net loss widened to US$4.11 million from US$3.58 million.
  • Over the first nine months of the fiscal year, sales more than doubled to US$50.56 million as losses also increased, highlighting the tension between rapid top-line expansion and the cost of building out its optics and infrared solutions business.
  • With revenue more than doubling year over year, we'll examine how this surge reshapes LightPath's investment narrative and risk profile.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Advertisement

LightPath Technologies Investment Narrative Recap

To own LightPath today, you have to believe its push from optical components into higher value infrared systems can justify sizable current losses. The latest results, with sales more than doubling to US$19.15 million in the quarter while net loss widened, reinforce that the key near term catalyst is execution on large camera and defense programs, and the biggest risk is that rising operating costs and weaker margins continue to outpace revenue growth. This news amplifies that risk rather than changing it.

The recent inclusion of LightPath in the S&P Technology Hardware Select Industry Index stands out against these earnings. Index membership can increase visibility and liquidity, which may support the company as it absorbs higher expenses and continues funding growth after its follow on offering and private placements. For investors focused on contract-driven upside, the US$9.6 million defense camera order and earlier multi year system awards remain central to the near term story.

Yet beneath the strong revenue ramp, investors should be aware of how rising losses and increased dependence on large defense orders could...

Read the full narrative on LightPath Technologies (it's free!)

LightPath Technologies' narrative projects $178.8 million revenue and $51.4 million earnings by 2029. This requires 41.7% yearly revenue growth and a $74.9 million earnings increase from -$23.5 million today.

Uncover how LightPath Technologies' forecasts yield a $15.98 fair value, a 17% upside to its current price.

Exploring Other Perspectives

LPTH 1-Year Stock Price Chart
LPTH 1-Year Stock Price Chart

Before this earnings jump, the most optimistic analysts were already assuming about US$81.1 million of revenue and a swing to roughly US$7.3 million in earnings by 2028, which is far more upbeat than consensus and leans heavily on recurring defense contracts. You can treat this quarter’s rapid growth as a chance to test whether that bullish view or a more cautious reading of execution and contract risk feels closer to your own expectations.

Explore 3 other fair value estimates on LightPath Technologies - why the stock might be worth just $14.00!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

Curious About Other Options?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:LPTH

LightPath Technologies

Designs, develops, manufactures, and distributes optical systems and assemblies in the United States.

Flawless balance sheet with high growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0